Inside the Booming mRNA Therapeutics MarketThe mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most transformative frontiers in oncology and biotechnology. These advanced ...
Takeda (TSE:4502/NYSE:TAK) announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluating its dengue vaccine, QDENGA®?(Dengue ...
George Tidmarsh’s short run directing the agency’s principal drug review office reportedly ended in controversy. Elsewhere, Moderna advanced a T-cell engager and Lilly expanded a production push for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback